Polysialic acid/KLH/QS-21 vaccine (Memorial Sloan-Kettering)

N/A

Report date: 2024/09/19 20:00:08

Base Information

Drug NamePolysialic acid/KLH/QS-21 vaccine (Memorial Sloan-Kettering)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSmall Cell Lung CarcinomaLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMabvax Therapeutics IncMemorial Sloan Kettering Cancer Center
Active IndicationsN/A
Inactive IndicationsSmall Cell Lung CarcinomaLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A